Table I Index
Table of Contents
|
Table I - 84 Vigo Incidence Rate1 by Primary Site and Sex: Cases Diagnosed in 1996, Indiana |
||||||
Primary Site |
Total |
Males | Females | |||
| Number | Rate | Number | Rate | Number | Rate | |
| All sites | 494 | 373.4 | 228 | 420.5 | 266 | 348.8 |
| Oral cavity and pharynx | 6 | 4.8** | * | # | * | # |
| Lip | * | # | * | # | * | # |
| Tongue | * | # | * | # | * | # |
| Major salivary glands | * | # | * | # | * | # |
| Floor of mouth | * | # | * | # | * | # |
| Gum and other mouth | * | # | * | # | * | # |
| Nasopharynx | * | # | * | # | * | # |
| Tonsil | * | # | * | # | * | # |
| Oropharynx | * | # | * | # | * | # |
| Hypopharynx | * | # | * | # | * | # |
| Pharynx and other oral cavity | * | # | * | # | * | # |
| Digestive system | 107 | 78.3 | 56 | 104.3 | 51 | 60.3 |
| Esophagus | * | # | * | # | * | # |
| Stomach | * | # | * | # | * | # |
| Small intestine | * | # | * | # | * | # |
| Colon excluding rectum | 48 | 32.7 | 25 | 45.9 | 23 | 23.4 |
| Rectum and rectosigmoid | 24 | 19.4 | 13 | 25.6** | 11 | 14.7** |
| Anus, anal canal, and anorectum | * | # | * | # | * | # |
| Liver and intrahepatic bile duct | * | # | * | # | * | # |
| Gallbladder | * | # | * | # | * | # |
| Other biliary | * | # | * | # | * | # |
| Pancreas | 15 | 10.9** | 9 | 15.9** | 6 | 7.7** |
| Retroperitoneum | * | # | * | # | * | # |
| Peritoneum | * | # | * | # | * | # |
| Other digestive organs | * | # | * | # | * | # |
| Respiratory system | 105 | 80.6 | 69 | 127.7 | 36 | 47.4 |
| Nasal cavity, ear, and sinuses | * | # | * | # | * | # |
| Larynx | 10 | 8.8** | 6 | 11.9** | * | # |
| Lung and bronchus | 91 | 68.6 | 59 | 108.6 | 32 | 41.0 |
| Trachea, pleura, and other respiratory organs | * | # | * | # | * | # |
| Bones and joints | * | # | * | # | * | # |
| Soft tissue (including heart) | * | # | * | # | * | # |
| Skin (excluding basal and squamous) | 20 | 15.4 | 10 | 17.3** | 10 | 14.4** |
| Melanoma of the skin | 19 | 14.8** | 9 | 16.1** | 10 | 14.4** |
| Other non-epithelial skin cancers | * | # | * | # | * | # |
| Breast | 83 | 61.7 | * | # | 82 | 109.8 |
| Female genital system | 31 | 22.3 | -- | -- | 31 | 39.8 |
| Cervix uteri | 6 | 4.1** | -- | -- | 6 | 7.8** |
| Corpus uteri | 12 | 9.2** | -- | -- | 12 | 16.6** |
| Uterus, NOS | * | # | -- | -- | * | # |
| Ovary | 11 | 8.1** | -- | -- | 11 | 14.1** |
| Vagina | * | # | -- | -- | * | # |
| Vulva | * | # | -- | -- | * | # |
| Other female genital organs | * | # | -- | -- | * | # |
| Male genital system | 33 | 25.8 | 33 | 61.3 | -- | -- |
| Prostate gland | 33 | 25.8 | 33 | 61.3 | -- | -- |
| Testis | * | # | * | # | -- | -- |
| Penis | * | # | * | # | -- | -- |
| Other male genital organs | * | # | * | # | -- | -- |
| Urinary system | 39 | 29.3 | 26 | 46.6 | 13 | 17.3** |
| Urinary bladder | 23 | 16.2 | 15 | 25.9** | 8 | 10.4** |
| Kidney and renal pelvis | 15 | 12.6** | 11 | 20.7** | * | # |
| Ureter | * | # | * | # | * | # |
| Other urinary organs | * | # | * | # | * | # |
| Eye and orbit | * | # | * | # | * | # |
| Brain and other nervous system | 6 | 4.8** | * | # | * | # |
| Brain | 5 | 4.2** | * | # | * | # |
| Other nervous system | * | # | * | # | * | # |
| Endocrine system | 9 | 7.4** | * | # | 8 | 13.4** |
| Thyroid gland | 8 | 6.8** | * | # | 8 | 13.4** |
| Other endocrine (including thymus) | * | # | * | # | * | # |
| Lymphoma | 29 | 23.0 | 13 | 22.8** | 16 | 22.7** |
| Hodgkin’s disease | 6 | 5.1** | * | # | * | # |
| Non-Hodgkin’s lymphoma | 23 | 17.9 | 11 | 19.2** | 12 | 15.9** |
| Multiple myeloma | * | # | * | # | * | # |
| Leukemia | 13 | 10.3** | 5 | 10.0** | 8 | 10.6** |
| Acute lymphocytic | * | # | * | # | * | # |
| Chronic lymphocytic | 5 | 3.4** | * | # | * | # |
| Acute myeloid | * | # | * | # | * | # |
| Chronic myeloid | * | # | * | # | * | # |
| Other leukemias | * | # | * | # | * | # |
| Other, ill-defined and unknown sites | 8 | 5.3** | * | # | * | # |
1 Per 100,000; Age-adjusted, 1970 U.S. Standard Million. Excludes in situ cancers except bladder, and also excludes basal and squamous cell carcinomas of the skin. * Fewer than 5 cases, number suppressed to protect confidentiality. ** Rates based on fewer than twenty cases are unstable. # Rate cannot be calculated. _______________________________________________________________ Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, January 2001 |
||||||